Skip to content

Category: Science Medical

Report on Government Services (RoGS) brings another wake up call for the NSW Government in relation to NSW Ambulance

By API User

Report on Government Services (RoGS) brings another wake up call for the NSW Government in relation to NSW Ambulance   EMBARGOED 5 Feb 2026   The Australian Paramedics Association (NSW) (APA (NSW)) are demanding the NSW Government urgently review the ongoing underfunding of NSW Ambulance (NSWA), warning that current investment levels are placing increasing strain … Continued

Menicon’s Largest Malaysia Plant Begins Commercial Production

By API User

– Strengthening Global Production Capacity for the Rapidly Growing 1-Day Lens Market NAGOYA, Japan–BUSINESS WIRE– Menicon Co., Ltd. is pleased to announce that its new manufacturing facility in Kedah, Malaysia, has commenced commercial production. The plant strengthens Menicon’s long-standing commitment to technological excellence, uncompromising quality, and a stable global supply of contact lenses. This press … Continued

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing

By API User

MINATO-KU, TOKYO, Japan & KOBE, Japan–BUSINESS WIRE– Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia … Continued

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide

By API User

SAN DIEGO–BUSINESS WIRE– Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) … Continued

ASA Response on Private Healthcare Australia (PHA) Consumer Research Report.

By API User

Sydney, 5 February 2026 The ASA acknowledge the consumer research report released today by Private Healthcare Australia (PHA).  Understanding and appreciating the pressures that patients are facing in healthcare is something medical specialists, such as anaesthetists, deal with every day. Anaesthetists provide approximately 7000 episodes of care to Australians in the private healthcare system each … Continued

Cleo Diagnostics (ASX.COV) Marks Ovarian Cancer Awareness Month

By API User

Cleo Diagnostics Marks Ovarian Cancer Awareness Month, Reinforcing its Commitment to Earlier Detection Cleo Diagnostics (ASX: COV) is recognising Ovarian Cancer Awareness Month this February, highlighting the urgent and unmet clinical need for earlier and more accurate detection of ovarian cancer. Ovarian cancer remains one of the most challenging cancers to diagnose early, with symptoms … Continued

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota

By API User

DUBLIN–BUSINESS WIRE– Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary … Continued

Number of Australians living with dementia growing

By API User

Data released by Dementia Australia today has revealed that the number of Australians living with dementia in 2026 has increased to an estimated 446,500¹ – a figure projected to more than double to over one million people by 2065.²   The data also highlights that dementia impacts Australians of all ages, with an estimated 29,000 people living with young onset dementia (a diagnosis of any kind of dementia when you’re aged 18-65). This … Continued

Number of Australians living with dementia growing

By API User

Data released by Dementia Australia today has revealed that the number of Australians living with dementia in 2026 has increased to an estimated 446,500¹ – a figure projected to more than double to over one million people by 2065.²   The data also highlights that dementia impacts Australians of all ages, with an estimated 29,000 people living with young onset dementia (a diagnosis of any kind of dementia when you’re aged 18-65). This … Continued